These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5317115)

  • 1. [Determination of metronidazole concentration in the urine of women with urogenital trichomoniasis].
    Korik LM
    Akush Ginekol (Mosk); 1971 Nov; 47(11):72. PubMed ID: 5317115
    [No Abstract]   [Full Text] [Related]  

  • 2. Metronidazole 1.5 gram dose for 7 or 14 days in the treatment of patients with chronic prostatitis caused by Trichomonas vaginalis: A randomized study.
    Vickovic N; Skerk V; Granic J; Vargovic M; Pasini M; Turcic P; Markotic A; Andrasevic S; Skerk V; Begovac J
    J Chemother; 2010 Oct; 22(5):364-5. PubMed ID: 21123162
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of urogenital trichomoniasis of both sexes with tinidazol (Fasygin)].
    Rainer A
    Wien Med Wochenschr; 1974 Oct; 124(42-43):625-6. PubMed ID: 4548265
    [No Abstract]   [Full Text] [Related]  

  • 4. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
    Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
    Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole.
    Biagi M; Slipke W; Smalley A; Tsaras G
    Int J STD AIDS; 2021 Jan; 32(1):89-91. PubMed ID: 33121364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men.
    Kawamura N
    Br J Vener Dis; 1978 Apr; 54(2):81-3. PubMed ID: 305809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trichomoniasis of the urogenital tract in patients hospitalized in 1976-1983].
    Szarmach H; Małyszko E; Wroński A; Niczyporuk W; Roszkiewicz J
    Z Hautkr; 1985 Feb; 60(3):261-4, 269. PubMed ID: 3873142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichomonas vaginalis: treatment questions and challenges.
    Secor WE
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):107-9. PubMed ID: 22339182
    [No Abstract]   [Full Text] [Related]  

  • 9. Premature with trichomoniasis: report of one case.
    Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
    Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy as a new approach to Trichomonas vaginalis inactivation.
    Silva Fonseca TH; Alacoque M; Silva Oliveira FM; Soares BM; Leite HV; Caliari MV; Gomes MA; Busatti H
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():91-95. PubMed ID: 29444462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secnidazole. A 5-nitroimidazole derivative with a long half-life.
    Videau D; Niel G; Siboulet A; Catalan F
    Br J Vener Dis; 1978 Apr; 54(2):77-80. PubMed ID: 305808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-Hydroxychalcones as an alternative treatment for trichomoniasis in association with metronidazole.
    das Neves RN; Sena-Lopes Â; Alves MSD; da Rocha Fonseca B; da Silva CC; Casaril AM; Savegnago L; de Pereira CMP; Ramos DF; Borsuk S
    Parasitol Res; 2020 Feb; 119(2):725-736. PubMed ID: 31853622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine pathogenicity of Trichomonas vaginalis & its susceptibility to metronidazole.
    Jayarao P; Gogate A; Deodhar L
    Indian J Med Res; 1991 Mar; 93():90-4. PubMed ID: 1855825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new antitrichomonal agent, tinidazole].
    Di Carlo R
    G Batteriol Virol Immunol; 1974; 67(7-12):257-72. PubMed ID: 4377559
    [No Abstract]   [Full Text] [Related]  

  • 17. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial.
    Price MA; Zimba D; Hoffman IF; Kaydos-Daniels SC; Miller WC; Martinson F; Chilongozi D; Kip E; Msowoya E; Hobbs MM; Kazembe P; Cohen MS
    Sex Transm Dis; 2003 Jun; 30(6):516-22. PubMed ID: 12782954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with secnidazole for trichomoniasis in the setting of metronidazole hypersensitivity.
    Kufel WD; Asiago-Reddy EA; Parsels KA; Sanyal S; Coyne JL
    Int J STD AIDS; 2021 Nov; 32(13):1271-1273. PubMed ID: 34392726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trichomonacidal properties of nimorazole].
    Cavier R; Cénac J
    Therapeutique; 1972; 48(5):391-4. PubMed ID: 4538614
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic prostatitis caused by Trichomonas vaginalis--diagnosis and treatment.
    Skerk V; Schönwald S; Granić J; Krhen I; Barsić B; Mareković I; Roglić S; Desnica B; Zeljko Z
    J Chemother; 2002 Oct; 14(5):537-8. PubMed ID: 12462437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.